provide a setting appropriate for MTM services, as recommended by the experts described in subsection (e);

submit to the Secretary a plan for achieving long-term financial sustainability;

where applicable, submit a plan for coordinating MTM services through local community health teams established in section 256a–1 of this title or in collaboration with primary care extension programs established in section 280g–12 of this title;

submit a plan for meeting the requirements under subsection (c); and

submit to the Secretary such other information as the Secretary may require.

performing or obtaining necessary assessments of the health and functional status of each patient receiving such MTM services;

formulating a medication treatment plan according to therapeutic goals agreed upon by the prescriber and the patient or caregiver or authorized representative of the patient;

selecting, initiating, modifying, recommending changes to, or administering medication therapy;

monitoring, which may include access to, ordering, or performing laboratory assessments, and evaluating the response of the patient to therapy, including safety and effectiveness;

performing an initial comprehensive medication review to identify, resolve, and prevent medication-related problems, including adverse drug events, quarterly targeted medication reviews for ongoing monitoring, and additional followup interventions on a schedule developed collaboratively with the prescriber;

documenting the care delivered and communicating essential information about such care, including a summary of the medication review, and the recommendations of the pharmacist to other appropriate health care providers of the patient in a timely fashion;

providing education and training designed to enhance the understanding and appropriate use of the medications by the patient, caregiver, and other authorized representative;

providing information, support services, and resources and strategies designed to enhance patient adherence with therapeutic regimens;

coordinating and integrating MTM services within the broader health care management services provided to the patient; and

such other patient care services allowed under pharmacist scopes of practice in use in other Federal programs that have implemented MTM services.

take 4 or more prescribed medications (including over-the-counter medications and dietary supplements);

take any “high risk” medications;

have 2 or more chronic diseases, as identified by the Secretary; or

have undergone a transition of care, or other factors, as determined by the Secretary, that are likely to create a high risk of medication-related problems.